FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

20448911000001105: Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 1 ml (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-May 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
69001501000001119 Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 1 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
69001601000001115 Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 1 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 1 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 1 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 1 ml Has VMP Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 1 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 1 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 1 ml Has specific active ingredient Magnesium glycerophosphate true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 1 ml Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 1 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Magnesium true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 1 ml Has basis of strength substance Magnesium true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution (Drug Tariff Special Order) 1 ml Is a True Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 1 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start